Chenxin Xu

1.3k total citations
51 papers, 769 citations indexed

About

Chenxin Xu is a scholar working on Molecular Biology, Artificial Intelligence and Automotive Engineering. According to data from OpenAlex, Chenxin Xu has authored 51 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Artificial Intelligence and 8 papers in Automotive Engineering. Recurrent topics in Chenxin Xu's work include Autonomous Vehicle Technology and Safety (8 papers), Anomaly Detection Techniques and Applications (7 papers) and Human Pose and Action Recognition (6 papers). Chenxin Xu is often cited by papers focused on Autonomous Vehicle Technology and Safety (8 papers), Anomaly Detection Techniques and Applications (7 papers) and Human Pose and Action Recognition (6 papers). Chenxin Xu collaborates with scholars based in China, United States and Singapore. Chenxin Xu's co-authors include Siheng Chen, Yanfeng Wang, Ya Zhang, Maosen Li, Wenjun Zhang, Weibo Mao, Qi Zhu, Jifeng Feng, Xinchao Wang and Yanjun Liu and has published in prestigious journals such as Nature Communications, IEEE Transactions on Pattern Analysis and Machine Intelligence and IEEE Transactions on Signal Processing.

In The Last Decade

Chenxin Xu

46 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenxin Xu China 14 250 236 178 161 129 51 769
Zewei Zhou China 16 325 1.3× 117 0.5× 431 2.4× 93 0.6× 169 1.3× 45 1.2k
Xintong Yan China 17 105 0.4× 125 0.5× 85 0.5× 250 1.6× 116 0.9× 62 997
Ziru Yang China 5 256 1.0× 96 0.4× 11 0.1× 68 0.4× 128 1.0× 8 432
Xiaolei Qu China 16 47 0.2× 108 0.5× 146 0.8× 117 0.7× 12 0.1× 52 660
Ning Bian China 12 201 0.8× 42 0.2× 52 0.3× 27 0.2× 38 0.3× 40 453
Santa Di Cataldo Italy 17 101 0.4× 211 0.9× 108 0.6× 290 1.8× 46 0.4× 48 862
Runkun Liu China 19 156 0.6× 17 0.1× 563 3.2× 26 0.2× 89 0.7× 46 1.1k
Yaxiao Liu China 16 114 0.5× 13 0.1× 113 0.6× 38 0.2× 81 0.6× 41 522
Yuchen Fang China 11 22 0.1× 25 0.1× 91 0.5× 105 0.7× 294 2.3× 28 672
Xiongwen Quan China 10 45 0.2× 50 0.2× 200 1.1× 61 0.4× 44 0.3× 38 782

Countries citing papers authored by Chenxin Xu

Since Specialization
Citations

This map shows the geographic impact of Chenxin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenxin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenxin Xu more than expected).

Fields of papers citing papers by Chenxin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenxin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenxin Xu. The network helps show where Chenxin Xu may publish in the future.

Co-authorship network of co-authors of Chenxin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Chenxin Xu. A scholar is included among the top collaborators of Chenxin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenxin Xu. Chenxin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lü, Hui, Yiqun Xia, Ying Yan, et al.. (2025). Panobinostat potentiates adagrasib-induced cell death by triggering autophagy in human non-small cell lung cancer. Cell Death Discovery. 11(1). 360–360.
2.
Yan, Ying, Chenyu Qiu, Junqi Wang, et al.. (2025). The glutamyl-prolyl-tRNA synthetase 1 inhibitor halofuginone exerts synergistic antitumor effects with bortezomib in colon cancer cells. Toxicology and Applied Pharmacology. 506. 117606–117606. 1 indexed citations
3.
Wang, Mingyu, et al.. (2024). Self-Supervised Bird’s Eye View Motion Prediction with Cross-Modality Signals. Proceedings of the AAAI Conference on Artificial Intelligence. 38(2). 1726–1734. 2 indexed citations
4.
He, Bowen, Xue Fang, Guokang Chen, et al.. (2024). Electronic communications between active sites on individual metallic nanoparticles in catalysis. Nature Communications. 15(1). 8614–8614. 6 indexed citations
5.
Xu, Chenxin, Guoyu Chen, Bo Yu, et al.. (2024). TRIM24 Cooperates with Ras Mutation to Drive Glioma Progression through snoRNA Recruitment of PHAX and DNA‐PKcs. Advanced Science. 11(29). e2400023–e2400023. 5 indexed citations
6.
Chen, Guoyu, Qiqi Shi, Chenxin Xu, et al.. (2024). Single-cell RNA transcriptomic analyses of tumor microenvironment of ovarian metastasis in gastric cancer. Cellular Oncology. 47(5). 1911–1925. 3 indexed citations
7.
Qiu, Chenyu, Xin Shen, Hui Lü, et al.. (2023). Combination therapy with HSP90 inhibitors and piperlongumine promotes ROS-mediated ER stress in colon cancer cells. Cell Death Discovery. 9(1). 375–375. 10 indexed citations
8.
Xu, Chenxin, et al.. (2023). Dynamic-group-aware networks for multi-agent trajectory prediction with relational reasoning. Neural Networks. 170. 564–577. 24 indexed citations
9.
Ye, Rui, et al.. (2023). FedFM: Anchor-Based Feature Matching for Data Heterogeneity in Federated Learning. IEEE Transactions on Signal Processing. 71. 4224–4239. 18 indexed citations
10.
Meng, Fankai, et al.. (2023). Performance Analysis of Multistage Thermoelectric Cooler with Water-Cooled. Journal of Physics Conference Series. 2442(1). 12028–12028.
11.
Shi, Qiqi, Bo Yu, Yingwen Zhang, et al.. (2023). Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex. Cellular Oncology. 46(6). 1763–1775. 2 indexed citations
12.
Zheng, Peisen, Yiqun Xia, Hui Lü, et al.. (2023). Combination of TrxR1 inhibitor and lenvatinib triggers ROS-dependent cell death in human lung cancer cells. International Journal of Biological Sciences. 20(1). 249–264. 5 indexed citations
13.
Zhang, Tingting, Chenxin Xu, Peisen Zheng, et al.. (2022). Glaucocalyxin B Attenuates Ovarian Cancer Cell Growth and Cisplatin Resistance In Vitro via Activating Oxidative Stress. Oxidative Medicine and Cellular Longevity. 2022(1). 6324292–6324292. 8 indexed citations
14.
Zhang, Hui, Chenxin Xu, Feng Jiang, & Jifeng Feng. (2022). A Three-Genes Signature Predicting Colorectal Cancer Relapse Reveals LEMD1 Promoting CRC Cells Migration by RhoA/ROCK1 Signaling Pathway. Frontiers in Oncology. 12. 823696–823696. 2 indexed citations
15.
Xu, Chenxin, Jun Wen, Yuanchuan Zhang, et al.. (2021). Fatty Acid Metabolism-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Patients With Colorectal Cancer. Frontiers in Oncology. 11. 704038–704038. 23 indexed citations
16.
Mao, Rui, et al.. (2021). Nomograms for Predicting Non-remission in Patients Who Underwent Bariatric Surgery: A Multicenter Retrospective Study in China. Obesity Surgery. 31(5). 1967–1978. 4 indexed citations
17.
Mao, Rui, Fan Yang, Zheng Wang, et al.. (2021). Clinical Significance of a Novel Tumor Progression-Associated Immune Signature in Colorectal Adenocarcinoma. Frontiers in Cell and Developmental Biology. 9. 625212–625212. 5 indexed citations
18.
Zhang, Hui, Chenxin Xu, Shi Chen, et al.. (2021). Hypermethylation of heparanase 2 promotes colorectal cancer proliferation and is associated with poor prognosis. Journal of Translational Medicine. 19(1). 98–98. 20 indexed citations
19.
20.
Xu, Chenxin, Haixia Cao, Shi Chen, & Jifeng Feng. (2019). <p>The Role Of Circulating Tumor DNA In Therapeutic Resistance</p>. OncoTargets and Therapy. Volume 12. 9459–9471. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zewei Zhou Breakdown of academic impact, for papers by Xintong Yan Breakdown of academic impact, for papers by Ziru Yang Breakdown of academic impact, for papers by Xiaolei Qu Breakdown of academic impact, for papers by Ning Bian Breakdown of academic impact, for papers by Santa Di Cataldo Breakdown of academic impact, for papers by Runkun Liu Breakdown of academic impact, for papers by Yaxiao Liu Breakdown of academic impact, for papers by Yuchen Fang Breakdown of academic impact, for papers by Xiongwen Quan
Rankless by CCL
2026